Highest Analyst Upside Stocks
ALC is part of our highest analyst upside stock list, indicating analysts have a price target way above the current price.
ALCON INC (ALC) Stock Price & Overview
NYSE:ALC • CH0432492467
Current stock price
79.74 USD
+1.73 (+2.22%)
At close:
79.74 USD
0 (0%)
After Hours:
The current stock price of ALC is 79.74 USD. Today ALC is up by 2.22%. In the past month the price increased by 3.13%. In the past year, price decreased by -13.83%.
ALC Key Statistics
52-Week Range71.55 - 99.2
Current ALC stock price positioned within its 52-week range.
1-Month Range73.12 - 79.86
Current ALC stock price positioned within its 1-month range.
- Market Cap
- 39.846B
- P/E
- 26.06
- Fwd P/E
- 23.38
- EPS (TTM)
- 3.06
- Dividend Yield
- 0.46%
ALC Stock Performance
Today
+2.22%
1 Week
+6.85%
1 Month
+3.13%
3 Months
+0.94%
Longer-term
6 Months +6.16%
1 Year -13.83%
2 Years +2.78%
3 Years +10.02%
5 Years +5.71%
10 Years N/A
ALC Stock Chart
ALC Stock Screens
ALC currently appears in the following ChartMill screener lists.
ALC Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ALC. When comparing the yearly performance of all stocks, ALC is a bad performer in the overall market: 77.6% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
ALC Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ALC. ALC has an excellent profitability rating, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ALC Earnings
On February 24, 2026 ALC reported an EPS of 0.78 and a revenue of 2.70B. The company missed EPS expectations (-1.57% surprise) and missed revenue expectations (-1.53% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported$0.78
Revenue Reported2.702B
EPS Surprise -1.57%
Revenue Surprise -1.53%
ALC Forecast & Estimates
20 analysts have analysed ALC and the average price target is 106.64 USD. This implies a price increase of 33.74% is expected in the next year compared to the current price of 79.74.
For the next year, analysts expect an EPS growth of 11.48% and a revenue growth 7.35% for ALC
Analysts
Analysts76
Price Target106.64 (33.73%)
EPS Next Y11.48%
Revenue Next Year7.35%
ALC Groups
Sector & Classification
ALC Financial Highlights
Over the last trailing twelve months ALC reported a non-GAAP Earnings per Share(EPS) of 3.06. The EPS increased by 0.33% compared to the year before.
Income Statements
Revenue(TTM)10.40B
Net Income(TTM)980.00M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.42% | ||
| ROA | 3.11% | ||
| ROE | 4.45% | ||
| Debt/Equity | 0.21 |
Chartmill High Growth Momentum
EPS Q2Q%8.33%
Sales Q2Q%9.08%
EPS 1Y (TTM)0.33%
Revenue 1Y (TTM)4.94%
ALC Ownership
Ownership
Inst Owners68.23%
Shares499.70M
Float486.45M
Ins Owners0.17%
Short Float %1.01%
Short Ratio2.84
ALC Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 31.48 | 62.032B | ||
| COO | COOPER COS INC/THE | 14.13 | 13.989B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.68 | 12.878B | ||
| SOLV | SOLVENTUM CORP | 10.24 | 11.69B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.42 | 5.306B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 17.07 | 4.21B | ||
| ICUI | ICU MEDICAL INC | 15.63 | 3.232B | ||
| HAE | HAEMONETICS CORP/MASS | 11.19 | 2.754B | ||
| XRAY | DENTSPLY SIRONA INC | 8.23 | 2.401B | ||
| NEOG | NEOGEN CORP | 26.95 | 1.988B | ||
| UFPT | UFP TECHNOLOGIES INC | 20.18 | 1.568B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.329B | ||
| BVS | BIOVENTUS INC - A | 12.39 | 783.273M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ALC
Company Profile
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,942 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
Company Info
IPO: 2019-04-09
ALCON INC
Rue Louis d'Affry 6
Fribourg FRIBOURG 1701 CH
CEO: David J. Endicott
Employees: 25942
Phone: 41589112222
ALCON INC / ALC FAQ
Can you describe the business of ALCON INC?
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,942 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
What is the current price of ALC stock?
The current stock price of ALC is 79.74 USD. The price increased by 2.22% in the last trading session.
What is the dividend status of ALCON INC?
ALCON INC (ALC) has a dividend yield of 0.46%. The yearly dividend amount is currently 0.34.
How is the ChartMill rating for ALCON INC?
ALC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the sector and industry classification for ALCON INC?
ALCON INC (ALC) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the expected growth for ALC stock?
The Revenue of ALCON INC (ALC) is expected to grow by 7.35% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the outstanding short interest for ALCON INC?
The outstanding short interest for ALCON INC (ALC) is 1.01% of its float.